["{\n\"step_by_step_thinking\": \"The relevant documents discuss the treatment of Hodgkin disease with radiation therapy (RT). The 54th annual Janeway Lecture discusses the use of radical RT for patients with large mediastinal mass and Stage IIIA spleen-positive disease, which produced survival and recurrence-free survival results equivalent to those achieved by combined modality treatment or chemotherapy alone. There is no mention of increased risk for lung cancer in this document.\",\n\"answer_choice\": \"B\"\n}"]